The chief executive officers of technology and biotech companies in Massachusetts are making millions of dollars.

Bank of America Global Healthcare Conference 2026 May 12, 2026 11:40 AM EDTCompany ParticipantsMatthew Klein - CEO ...

Strategic focus on Intelligent Product Lifecycle vision Solid execution in Q2'26 Constant currency ARR growth of 8.5% excluding divested businesses Operating ...

Detailed price information for Palvella Therapeutics Inc (PVLA-Q) from The Globe and Mail including charting and trades.

PTC Therapeutics (NASDAQ:PTCT) reported a record first quarter for product revenue and raised its 2026 revenue outlook, ...

First quarter 2026 total revenue of $273 million, including $226 million of product revenue, supporting full-year 2026 guidance raise - - Global Sephience (sepiapterin) ...

PTC Therapeutics, Inc., (NASDAQ: PTCT) today announced a corporate update and financial results for the first quarter ended March 31, 2026.

PTC (NASDAQ: PTC) today reported financial results for its second fiscal quarter ended March 31, 2026. "PTC delivered solid financial results i ...

PTC Inc. PTC is scheduled to report second-quarter fiscal 2026 results on May 6, after market close. For the quarter, PTC anticipates revenues in the $710-$770 million band. Non-GAAP EPS is ...

Detailed price information for Jazz Pharma Plc (JAZZ-Q) from The Globe and Mail including charting and trades.

PTC News Desk: The Indian Rupee fell to a new record low of 92.44 against the US Dollar during intra-day trading on Friday, dropping 19 paise from its previous close. The fall came as global crude oil ...

With the writing apparently on the wall, PTC Therapeutics has called off its latest bid for FDA approval of its Duchenne muscular dystrophy (DMD) drug Translarna. Late Thursday, PTC revealed that it ...